Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to -$1.4 million.

  • Ekso Bionics Holdings' Consolidated Net Income rose 4775.57% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.3 million, marking a year-over-year increase of 580.51%. This contributed to the annual value of -$10.7 million for FY2024, which is 3039.44% up from last year.
  • Per Ekso Bionics Holdings' latest filing, its Consolidated Net Income stood at -$1.4 million for Q3 2025, which was up 4775.57% from -$4.0 million recorded in Q2 2025.
  • Over the past 5 years, Ekso Bionics Holdings' Consolidated Net Income peaked at -$1.4 million during Q3 2025, and registered a low of -$4.6 million during Q4 2021.
  • Its 5-year average for Consolidated Net Income is -$3.4 million, with a median of -$3.4 million in 2021.
  • Examining YoY changes over the last 5 years, Ekso Bionics Holdings' Consolidated Net Income showed a top increase of 4775.57% in 2025 and a maximum decrease of 6770.44% in 2025.
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' Consolidated Net Income stood at -$4.6 million in 2021, then increased by 1.87% to -$4.5 million in 2022, then grew by 21.92% to -$3.5 million in 2023, then skyrocketed by 34.88% to -$2.3 million in 2024, then skyrocketed by 37.96% to -$1.4 million in 2025.
  • Its last three reported values are -$1.4 million in Q3 2025, -$4.0 million for Q2 2025, and -$3.5 million during Q1 2025.